What’s the short thesis now? Here’s what I can come up with: 1) Generics somehow win and enter market early This should resolve itself within a couple months 2) Product doesn’t sell I think we’ve already seen demand is there with weekly script growth 3) Insurance slow to cover Should resolve itself with FDA label in next month or so 4) Giant Asteroid Shit.